NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 30, 2026 — OS Therapies advances OST-HER2 immunotherapy for osteosarcoma with FDA RMAT designation. Phase 2b results show significant survival improvement. Potential 2026 launch with commercial partner Eversana.
October 27, 2025 — Izotropic's IzoView Breast CT Imaging System combines 3D AI technology for enhanced breast cancer detection in the $9B medical imaging market. Learn about this breakthrough medical device.
October 27, 2025 — New research reveals chemotherapy may damage brain's waste drainage system, causing chemo brain affecting 75% of cancer patients. Study offers hope for relief from cognitive symptoms.
October 27, 2025 — NanoViricides presents antiviral pipeline at PODD 2025. Lead candidate NV-387 advances to Phase II trials for MPox & respiratory infections. Broad-spectrum nanoviricide technology targets multiple viruses.
October 27, 2025 — Oncotelic Therapeutics leads nanomedicine revolution with Deciparticle platform, transforming cancer drug delivery. Breakthrough technology improves bioavailability and reduces toxicity in oncology treatments.
October 27, 2025 — Nutriband founder Gareth Sheridan returns as CEO to lead AVERSA Fentanyl abuse-deterrent patch development toward 2026 NDA filing with $80-200M sales potential.
October 27, 2025 — Aditxt subsidiary Pearsanta begins clinical study for blood-based endometriosis test. Non-invasive diagnostic could revolutionize early detection of condition affecting millions of women worldwide.
October 27, 2025 — Branded Legacy advances intranasal drug delivery platform for opioid crisis response. New unitary device mold enables scalable production of life-saving treatments including inhaled naloxone program.
October 27, 2025 — Annovis Bio completes $3.4M registered direct offering to fund neurodegenerative disease drug development for Alzheimer's and Parkinson's treatments through clinical trials.
October 27, 2025 — American Heart Association launches Digital Health in Cardiac Care certification to train healthcare providers in telehealth tools, remote monitoring, and digital cardiac care management for chronic conditions.
October 27, 2025 — Trump administration denies FEMA aid for Western MD floods as federal shutdown continues. MD senators oppose GOP back pay limits while SNAP-Ed defunded and Obamacare premiums rise.
October 27, 2025 — Maryland's SNAP-Ed program defunded, eliminating nutrition education for 640,000 residents. 70 jobs lost, 700 community partners affected across state.
October 27, 2025 — Rita Case donates $2M to Cleveland Clinic Weston Hospital, supporting healthcare research and education. The gift names the Rita and Rick Case Corridor in recognition.
October 25, 2025 — VOCIC mobility solutions transform lives through scooters, electric wheelchairs & community partnerships. Discover how accessibility products restore independence & create inclusive communities.
October 25, 2025 — DEFI Smart Pillbox 14 launches on Kickstarter featuring AI medication scheduling, real-time tracking, and caregiver monitoring to ensure perfect medication adherence.
October 24, 2025 — Izotropic's AI-powered breast CT imaging system gains recognition for improving cancer detection in dense breast tissue. Learn how this technology addresses critical gaps in breast cancer screening.
October 24, 2025 — New LED light therapy selectively destroys cancer cells while preserving healthy tissues, potentially revolutionizing cancer treatment with fewer side effects than traditional chemotherapy and radiation.
October 24, 2025 — Datavault AI partners with Wellgistics to integrate blockchain PharmacyChain technology for transparent prescription tracking from script to fulfillment, enhancing patient safety.
October 24, 2025 — Lantern Pharma (NASDAQ: LTRN) announces presentation at ThinkEquity Conference showcasing AI-driven cancer drug discovery platform with $15B market potential and advanced clinical pipeline.
October 24, 2025 — Nutriband's AVERSA Fentanyl patch uses abuse-deterrent technology to combat opioid misuse. With $200M-$800M market potential and 2026 FDA filing planned, this innovation addresses the opioid crisis.